Journals / Türk Yoğun Bakım Derneği Dergisi / 2017 / Cilt: 15 - Sayı: 3

Rhabdomyolysis and Renal Insufficiency Due to Synthetic Cannabinoid Intoxication

Sentetik Kannabinoid İntoksikasyonuna Bağlı Rabdomiyoliz ve Böbrek Yetmezliği

Pages
141–144
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case, with severe rhabdomyolysis, we tried to discuss the treatment challenges of the patient examined in intensive care unit with the history of bonsai use

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bonsai is the street name of synthetic marijuana, which is a psychoactive substance.
📊
Key Findings & Data:Since synthetic cannabinoids are easily accessible and cheap, their use is becoming widespread day by day.
💡
Conclusion & Impact:In this case, with severe rhabdomyolysis, we tried to discuss the treatment challenges of the patient examined in intensive care unit with the history of bonsai use
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bonsai is the street name of synthetic marijuana, which is a psychoactive substance. Since synthetic cannabinoids are easily accessible and cheap, their use is becoming widespread day by day. It can cause not only various clinical symptoms but also severe rhabdomyolysis. In this case, with severe rhabdomyolysis, we tried to discuss the treatment challenges of the patient examined in intensive care unit with the history of bonsai use

Özet

Bonzai psikoaktif bir madde olup, sentetik esrarın sokakta kullanılan ismidir. Sentetik kannabinoidler kolay ulaşılması ve ucuz olması nedeniyle kullanımı günden güne yaygınlaşmaktadır. Bonzai çeşitli klinik bulgularla görülebileceği gibi şiddetli rabdomiyolize de sebep olabilir. Biz yoğun bakım servisinde takip ettiğimiz bonzai kullanım öyküsü olan ciddi rabdomiyoliz ile seyreden olguda tedavi zorluklarını tartışmaya çalıştık

🔖

Cite This Article

ORHAN, S., İNAL, S., GÜLSOY, K. Y., DEMİREL, S., EROĞLU, F. (2022). Rhabdomyolysis and Renal Insufficiency Due to Synthetic Cannabinoid Intoxication. Türk Yoğun Bakım Derneği Dergisi, Cilt: 15 - Sayı: 3, 141–144. https://ajindex.com/articles/643451

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Fattore L, Fratta W. Beyond THC: The New Generation of Cannabinoid Designer Drugs. Front Behav Neurosci 2011;5:60
  2. Ashton JC, Wright JL, McPartland JM, Tyndall JDA. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Curr Med Chem 2008;15:1428-43
  3. Huffman JW, Marriott KC. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr Top Med Chem 2008;8:187-4
  4. Harris CR, Brown A. Synthetic cannabinoid intoxication: a case series and review. J Emerg Med 2013;44:360-6
  5. Sherpa D, Paudel BM, Subedi BH, Chow RD. Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high. J Community Hosp Intern Med Perspect 2015;5:27540
  6. Zhao A, Tan M, Maung A, Salifu M, Mallappallil M. Case Report Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids Case Reports in Nephrology Volume 2015, Article ID 235982, 4 pages
  7. Ergül DF, Ekemen S, Yelken BB. Synthetic Cannabinoid ‘Bonzai’ Intoxication: Six Case Series. Turk J Anaesth Reanim 2015;43:347-51
  8. EarlyWarning System. (2009).Available at: http://www.emcdda.europa.eu/ themes/new-drugs/early-warning [accessed October 23, 2009]
  9. Laaris N, Good CH, Lupica CR. D9- tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology 2010;59:121-7
  10. Teske J, Weller JP, Fieguth A, Rothämel T, Schulz Y, Tröger HD. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol3-yl)methanone (JWH-018) in human serum by liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:2659-63
  11. Ronco C. CommentaryExtracorporeal therapies in acute rhabdomyolysis and myoglobin clearance. Crit Care 2005;9:141-2
  12. Swaroop R, Zabaneh R. and Parimoo N. Case report Open Access Plasmapheresis in a patient with rhabdomyolysis: a case report. Cases Journal 2009;2:8138
  13. Paaske WP, Bagl P, Lorentzen JE, Olgaard K. Plasma exchange after revascularization compartment syndrome with acute toxic nephropathy caused by rhabdomyolysis. J Vasc Surg 1988;7:757-8.